11th International Congress of Human Genetics

Session Details

Poster Session 1a

Tuesday, 8 August 2006 15:30 -16:30

Exhibition Hall 2

Genomic re-arrangements account for ~8% of deleterious mutations in the in BRCA1 and BRCA2 genes in a population at risk for HBOC
  • Dr Peter J Ainsworth, University of Western Ontario / London Health Sciences Centre, Canada
  • The Psychosocial Impact of Familial Adenomatous Polyposis on Young Adults
  • Dr Lesley J Andrews, Prince of Wales Hospital, Sydney, Australia
  • Activation of the repair of DNA double strand breaks by non-homologous end joining in human BCR/ABL-expressing cells by imatinib mesylate
  • Janusz Blasiak, Department of Molecular Genetics, University of Lodz, Poland
  • Molecular variants of the NBS1 gene in primary pediatric brain tumors
  • Krystyna H Chrzanowska, Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, Poland
  • Fibronectin in in human bone tissue remodelling
  • Regine Dahse, Helios Klinikum Erfurt GmbH, Germany
  • A rare composite karyotype in a Filipino with diffuse large B-cell cell lymphoma
  • Ma Luisa D Enriquez, Philippines
  • Hereditary breast cancer in women with cancer family history recruited from a community-based sample
  • Roberto Giugliani, Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Brazil
  • Female with both a BRCA1 and BRCA2 mutation
  • Ms Annette Hattam, Queensland Clinical Genetics Service, Australia
  • Integrated Use of Genetics and Genomics to Accelerate Development of Targeted Cancer Drugs
  • Dr Robert Hollingsworth, GlaxoSmithKline, United States
  • Implementation of Molecular diagnosis of the BCR/ABL transcript in children with LLA in Costa Rica. First Report
  • Dr Gerardo A Jimenez, Universidad de Costa Rica, Centro de Investigación en Hematología y Trastornos Afines, Costa Rica
  • Should health care providers have a duty to warn family members of individuals with an HNPCC-predisposing mutation? A survey of patients
  • Kelly E Kohut, Memorial Sloan-Kettering Cancer Center/ Ontario Familial Colon Cancer Registry, United States
  • Identification of a putative prostate tumor suppressor gene on chromosome 18q22.3
  • Robin J Leach, University of Texas Health Science Center at San Antonio, United States
  • Gene expression and mutational analysis of a minimal region of human chromosome 8p specifically disrupted in colorectal liver metastases
  • Dr Donia P Macartney, Institute of Environmental Science and Research, New Zealand
  • DNA aberrations in an atypical skin cancer cohort
  • Dr David J Maguire, Australia
  • Lyn R Griffiths, Genomics Research Centre, Australia
  • High throughput screening of genomic copy number changes in chronic lymphocytic leukaemia using array comparative genomic hybridisation
  • So Young Moon, Cancer Genetics Research Group, Department of Pathology, Christchurch School of Medicine and Health Sciences, New Zealand
  • Kallikrein 15 (KLK15): analysis of splice variants and single nucleotide polymorphisms, and their association with ovarian and prostate cancer
  • Ms Tracy O'Mara, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia
  • Identification of cryptic aberrations and characterization of translocation breakpoints in high hyperdiploid childhood ALL using genome-wide array CGH
  • Kajsa Paulsson, Lund University Hospital, Sweden
  • Wild type BRCA2 restores chromosomal stability and cytokinesis in the tumor cells harboring a rare BRCA2 allele
  • Evgeny Sagulenko, German Cancer Research Center, Germany
  • Are polymorphisms in the toll-like receptors associated with disease risk in HNPCC?
  • Prof Rodney J Scott, Hunter Area Pathology Service, University of Newcastle, Hunter Medical Research Institute, Newcastle, Australia
  • Making sense of dHPLC results using knowledge of ancestral haplotypes for BRCA1
  • Dr Elizabeth L Spriggs, Molecular Diagnostic Laboratory, Health Sciences Centre, Departments of Biochemistry & Medical Genetics and Pediatrics & Child, Canada
  • Genetic Polymorphisms in Xenobiotic Clearance Genes and their Influence on Disease Expression in HNPCC patients
  • Ms Bente A Talseth, Discipline of Medical Genetic, Faculty of Health, University of Newcastle, and the Hunter Medical Research Institute, NSW, Australia
  • Familial, clinical and immunophenotypical characterization of HNPCC-suspected patients. Improved family selection for genetic testing analyzing Cdk2 and ß-catenin expression
  • Miguel Urioste, Spanish National Cancer Centre (CNIO), Madrid, Spain
  • KRT8/18 expression differentiates distinct molecular subtypes of grade 3 invasive ductal carcinomas
  • Logan C Walker, Christchurch School of Medicine and Health Sciences, New Zealand
  • Method of Three-Dimensional (3D) Analysis of Telomeric Changes in Primary Mouse and Human Cells
  • Katalin Benedek, MTC, Karolinska Institute, Sweden
  • Occurrence of the Burkitt translocation t(8;14) or t(8;22) and the follicular lymphoma translocation t(14;18) together in 7 patients with NHL
  • Shan Lin, Department of Cytogenetics, Children's Hospital at Westmead, Australia
  • Cytologic, cytogenetic and molecular cytogenetic aberrations in plasma cells of patients with multiple myeloma (MM)
  • Ursula M Paetzold, Institute of Human Genetics, University Bonn, Germany
  • Identification of a Novel 11;17 Translocation Involving the NUP98 Gene in Acute Myeloid Leukemia
  • Jocelyn C Reader, University of Maryland School of Medicine, United States
  • Discovery of novel cytogenetic abnormalities in patients with develomental delay, dysmorphology, and mental retardation
  • Swaroop Aradhya, Stanford University, United States
  • De novo recombinant chromosome 11 with partial monosomy 11q25-ter and partial trisomy 11p15.1-ter; first case report and discussion of the underlying mechanism
  • Ms Jennifer L Bryan, Cytogenetics Laboratory, Mater Health Services, Brisbane, Queensland, Australia
  • In search of the minimal critical region associated with the distinctive Monosomy 1p36 phenotype.
  • Mrs Nicole Chia, Cytogenetics, ACT Pathology , Canberra Hospital, Australia
  • SNP-GeneChip based copy number assessment improves the resolution of chromosomal abnormalities
  • Ms Marylou Doody, Mater Pathology, Mater Health Services, Brisbane, Australia
  • A Case report of Zimmermann-Laband syndrome caused by a Chromosomal Insertion: ins(12;8)(p11.2;q11.2q24.3)
  • Engela M Honey, Senior Lecturer, Department of Genetics, University of Pretoria, South Africa
  • Comparison of cytogenetic analyses of amniotic fluid specimens following a diagnosis of intrauterine fetal demise (IUFD) and specimens derived from products of conception (POC)
  • Dr Judith F Knops, Genzyme Genetics, Santa Fe, NM, United States
  • Sex chromosomes characteristics of intersex patients in Indonesia
  • Nanis S Marzuki, Eijkman Institute for Molecular Biology, Jakarta, Indonesia
  • Small Supernumerary X Chromosome in a Boy with Mild Phenotype
  • Hironao Numabe, Department of Biomedical Ethics, Kyoto University Graduate School of Medicine, Japan
  • cIg-FISH optimization on fixed bone marrow cells
  • Helena Podgornik, Clinical Center Ljubljana, Hematology Department, Slovenia
  • Fragile sites in autosomes: Interchromosomal distribution in patients before ICSI-treatment and their possible influence on the success of the therapy
  • Gesa Schwanitz, Germany
  • Ursula M Paetzold, Institute of Human Genetics, University Bonn, Germany
  • Katrin van der Ven, Department of Obstetrics and Gynecology, University Bonn, Germany
  • Aniridia and the 11p13 region: G-banding difficulties and the requirement for FISH/CGH Array to define PAX6 and WT1 status
  • Mr Luke St Heaps, Department of Cytogenetics, The Children's Hospital at Westmead, Sydney, New South Wales., Australia
  • Antisense oligonucleotide induced dystrophin expression in mdx mouse cardiac cells
  • A/Prof Dr Steve D Wilton, Experimental molecular medicine group, Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australia
  • The use of m-band to identify dual inversions in chromosome 4
  • Adrian C Zordan, Victorian Cancer Cytogenetics Service, Australia
  • Extensive Acrochordons and Islet-cell Tumor in Tuberous Sclerosis associated with TSC2 mutations
  • Dusica Babovic-Vuksanovic, Mayo College of Medicine, United States
  • Williams-Beuren syndrome: Additional atypical clinical symptoms and deletion size
  • Rafael Camara, Division of Medical Genetics, University Children's Hospital Basel, Switzerland
  • Adams-Oliver Like Syndrome with Novel CNS Anomalies: A New Syndrome?
  • Jane Gillis, Hospital for Sick Children, Department of Metabolic and Clinical Genetics; University of Toronto., Canada
  • Using the Multi-Axial Diagnostic System (MADS): Twenty Years Experience
  • Dr Yves Lacassie, Louisiana State University Health Sciences Center and Children's Hospital New Orleans, La, United States
  • Complex phenotype and development of an atypical rhabdoid tumour in a boy with a 46,XY,inv(22)(p11.2q12.3).ish inv(22)(WCP22+,TUPLE1+,BCR-,EWS+,MS607+)
  • A/Prof Julie M McGaughran, Queensland Clinical Genetics Service, Brisbane, Australia
  • Prader-Willi syndrome: Molecular analysis by real-time PCR
  • Ms Teresa B Munce, Mater Pathology, Mater Health Services, South Brisbane AND School of Molecular and Microbial Sciences, University of Queensland, Australia
  • Skeletal phenotype in patients with LRP5 mutations – Evidence for a significant carrier phenotype
  • Anne Saarinen, Folkhälsan Institute of Genetics and Department of Medical Genetics, University of Helsinki, Finland
  • Abnormalities of tooth size and form associated with familial hypodontia
  • Prof Emilia M Severin, "Carol Davila"Univ Med Pharm - Bucharest, Romania
  • The Dysmorphology of Orofacial Clefting: Syndromes and Birth Defects associated with Cleft Lip and Palate in Victoria, Australia
  • Tiong Yang Tan, Genetic Health Services Victoria, Royal Children’s Hospital, Melbourne, Australia, Australia
  • Clinical features of CHARGE Syndrome and 13q22 deletion
  • Dr Pilar Ureta, Hospital Clínico Universidad de Chile, Chile
  • A Comparison Study of Renin and Angiotensin AIILevels in Normotensive Glaucoma Patients and Normal Individuals
  • Dr Hongmin Yun, Department of Ophthalmology, Peking University Shenzhen Hospital, Shenzhen 518036, China
  • Wei Wang, China
  • Novel mutations in CYP21 gene in patients with 21-hydroxylase deficiency in Iran
  • Mohammad R Abbaszadegan, Division of Human Genetics, Immunology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences (MUMS, Iran
  • Preimplantation genetic diagnosis (PGD) for 45,XY,der(4)t(4;22)(q35;q11.2) with subsequent prenatal karyotype revealing a jumping translocation (JT)
  • Christie Beale, Sydney Genetics Sydney IVF, Australia
  • Gene expression profiling of murine spermatogenesis leads to the cloning and characterization of Ard2, a novel mouse Ard1 homologue that is preferentially expressed starting from meiosis
  • Wai-Yee Chan, National Institute of Child Health and Human Development, National Institutes of Health, United States
  • Prenatal diagnosis of Ritscher-Schinzel syndrome
  • Rena E Falk, Cedars-Sinai Medical Center, United States
  • Choices couples make in prenatal testing for Huntington’s disease
  • Ms Maria Kaps, Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, Australia
  • Prenatal Diagnosis of Pallister-Killian Syndrome
  • Pauline J McGrath, Queensland Clinical Genetics Service, Australia
  • Polymorphisms of some candidate genes in diabetic nephropathy in Romanian population
  • Toma Mihai
  • Evolutionary alteration of interaction between poly-glutamine tract in ATAXIN-1 and PQBP1
  • Tatsuaki Kurosaki, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Japan
  • Expression of Silent Mutations in Disease Phenotype
  • Ms Janaki H Shah, School of Biomolecular and Biomedical Sciences, Griffith University & Dept of Endocrinology, Mater Childrens Hospital, Australia
  • Cloning, expression and characterization of a novel human MDSRP from CD34+ stem/progenitor cells
  • Wei Wang, China
  • The attitudes and views of UK non-genetics trainee medical specialists to genetics in their training programmes and clinical practice
  • Peter A Farndon, NHS National Genetics Education and Development Centre, United Kingdom
  • What do non-genetics trainee medical specialists need to know about genetics for clinical practice?
  • Peter A Farndon, NHS National Genetics Education and Development Centre, United Kingdom
  • Development of an Enterprise Bargaining Agreement (EBA) for Victorian Genetic Counsellors
  • Susan Fawcett, Genetic Health Services Victoria, Royal Children’s Hospital, Parkville, Victoria, Australia, Australia
  • The finding of BRCA1 and BRCA2 in the same individual presents unique counselling difficulties
  • Ms Kim L Frumar, North Coast Area Health Service, Port Macquarie, NSW, Australia, Australia
  • Genetics education in Japanese medical schools: A survey
  • Yoshimitsu Fukushima, Department of Medical Genetics, Shinshu University School of Medicine, Japan
  • Evolution of the Genetic Counselling Profession - Career Pathways and Sole Practitioners
  • Carolyn L James, Queensland Clinical Genetics Service, Australia
  • Creating an International MSc in Human Genetics
  • Prof Michael A Patton, St George's University London, United Kingdom
  • A de novo unbalanced reciprocal translocation raises the question of an increased risk for chromosomal aberrations of ICSI outcomes?
  • Sigrun Sodia, Institute of Medical Biology and Human Genetics, Medical University of Graz, Austria
  • Werner Emberger, Institute of Medical Biology and Human Genetics, Medical University of Graz, Austria
  • Promotion and Marketing of the Jameslink-OSUCAP - A Web Tool to Assess Cancer Risk
  • Mr Kevin M Sweet, The Ohio State University Comprehensive Cancer Center, United States
  • Population genetic structure, ancestry, admixture and confounding in the Reynold-Stanford cardiovascular case-control association study
  • Analabha Basu, University of California, San Francisco, India
  • Consanguinity, fertility and early mortality in Sweden during the 18th and 19th centuries
  • Prof Alan H Bittles, Edith Cowan University, Australia
  • Cantu Syndrome: Two new unrelated cases
  • Dr Jose M Cantu, Instituto de Genetica Humana, CUCS, Universidad de Guadalajara, Mexico
  • Genetic boundaries in the greater Himalayan region: the impact of geographical and linguistic barriers on the maternal and paternal gene pools
  • Denise R Carvalho-Silva, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, United Kingdom, United Kingdom
  • Wheat flour fortification with folic acid reduces the rate of neural tube defects, has no effect on the rate of multiple births, and has been associated with a decrease in the stillbirth rate in Chile
  • Fanny M Cortés, INTA, University of Chile, Chile
  • Contribution to the family aggregation studies of Gastroesophageal Reflux Disease (GERD) and cancer in general, in patients with GERD and Esophagus Cancer (EC)
  • Prof Dertia V Freire-Maia, São Paulo Federal University (UNIFESP), Brazil
  • Identification of GATA2 polymorphisms associated with early onset coronary artery disease
  • Simon G Gregory, Center for Human Genetics, Duke University, Durham, NC, United States
  • Tracking the evolutionary history of the Warrior gene across the South Pacific: Implications for genetic epidemiology of behavioral disorders
  • Mr David A Hall, Institute of Environmental Science and Research, New Zealand
  • Why didn't you tell me? Disclosure about genetic risk in infertility patients
  • Mrs Andrea J Hayward, Genesis Clinical Genetics, Australia
  • Susceptibility genes in New Zealand Crohn’s disease patients
  • Ms Jiwon Hong, Department of Molecular Medicine & Pathology, University of Auckland, Auckland, New Zealand
  • Candidate Gene Association Analysis of Severe Lung Injury in Pediatric Community Acquired Pneumonia
  • Julia Krushkal, University of Tennessee Health Science Center, United States
  • Fourth female case of Myhre Syndrome
  • Dr María G Lopez-Cardona, Instituto de Genetica Humana, CUCS, Universidad de Guadalajara, Mexico
  • Glutathione-S-transferase M1 polymorphisms and susceptibility to esophageal cancer among three Chinese minorities: the Kazakh, Uygur and Tajik
  • Dr Xiao-Mei Lu, Medical Research Center, 1st Teaching Hospital, Xinjiang Medical University, Urumqi 830054, Xingjian Uygur Autonomous Region, C, China
  • Wei Wang, China
  • Influence of Serotonin Transporter and Receptor Gene Polymorphisms on Cognitive Abilities in a Community-based Australian Sample
  • Holly A Mack, The Centre for Mental Health Research, Australia
  • ADAM33 Genotype as a Predictor of Chronic Obstructive Pulmonary Disease
  • Ms Alokananda Maitra, Institute of Environmental Science and Research, New Zealand
  • Distribution of glucose-6-phosphate dehydrogenase deficiency in Southeast Asia and Oceania
  • Ms Aya Ninokata, Graduate school of Science, The University of Tokyo, Japan
  • Bivariate Mixture Modelling of Age at Onset Data in Twins
  • Mr Christopher J Oldmeadow, Queensland University of Technology, Australia
  • Segregation of t(19;22) in five generations resulting in three cases of Phelan-McDermid syndrome
  • Mary C Phelan, Molecular Pathology Laboratory Network, United States
  • Islands of euchromatic-like sequence and expressed genes within the short arm of HSA21: sequence and copy number variability
  • Alexandre Reymond, Center for Integrtaive Genomics, University of Lausanne, Switzerland
  • Frequency of hemoglobin S and C and their association with malaria episodes in two populations of different ethnic origins in eastern Sudan
  • Niven A Salih, Institute of Endemic Diseases,University of Khartoum,Sudan, Sudan
  • Familial aggregation of nephropathy in FAP-I ATTRV30M
  • Alda Sousa, ICBAS and IBMC, Univ Porto, Portugal
  • Phylogeography of Y-chromosomal lineages in Siberia and Cenral Asia
  • Vadim A Stepanov, Institute for Medical Genetics, Russia
  • Interactions between SRD5A2 V89L and VDR FokI Polymorphisms in Relation to Risk for Prostate Cancer
  • Kathleen C Torkko, University of Colorado at Denver and Health Sciences Center, United States
  • An integrated data analysis workflow for the characterization of genetic events in Glioblastoma multiforme using Affymetrix GeneChip® U133 plus 2 expression arrays, Mapping 100K arrays and RPCI BAC arrays
  • Yaron Turpaz, Affymetrix, Inc., United States
  • A single-nucleotide polymorphism in ABCC11 gene is the determinant of human earwax type
  • Dr Koh-ichiro Yoshiura, Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki Japan, Japan
  • Inhibin A parameters and prenatal screening for Down's syndrome
  • David A Aitken, Institute of Medical Genetics, United Kingdom
  • Genetic testing for Facioscapulohumeral muscular dystrophy: an update
  • Egbert Bakker, Leiden University Medical Center, The Netherlands
  • Genetic Services for Hereditary Breast/Ovarian and Colorectal Cancers: Physicians’ awareness, utilization and satisfaction
  • Dr June C Carroll, Mount Sinai Hospital, University of Toronto, Canada
  • First trimester serum markers of adverse pregnancy outcome.
  • Dr Jennifer A Crossley, Institute of Medical Genetics, United Kingdom
  • Prenatal screening for Down's syndrome: 5 years experience of combined ultrasound and biochemical screening in the first trimester
  • Dr Jennifer A Crossley, Institute of Medical Genetics, United Kingdom
  • Genetic testing for rare disorders – maximising cost-effectiveness
  • Dr Kathie Friend, Department of Genetic Medicine, Women's and Children's Hospital, Adelaide, Australia
  • Are Referral Patterns for Prader Willi and Angelman Syndromes Bimodal – “Early” and “Late”?
  • Ms Julianne E Jackson, The Children's Hospital at Westmead, NSW Australia, Australia
  • An Integrated Program for the Definition of the Genetic Types of Neuronal Ceroid Lipofuscinoses (NCL) in Latin America
  • Romina Kohan, Centro de Estudio de las Metabolopatías Congénitas-CEMECO-Facultad de Ciencias Médicas, Universidad Nacional de Córdoba., Argentina
  • Prof Inés Noher de Halac, PhD, Centro de Estudio de las Metabolopatías Congénitas-CEMECO-Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, CONIC, Argentina
  • Health perception in individuals requesting pre-symptomatic testing for late-onset neurological diseases
  • Drª Ângela M T Leite, Instituto de Biologia Molecular e Celular, Univ. Porto, Portugal, Portugal
  • Investigation of genetic polymorphism of NAD(P)H quinine oxidoreductase 1 (NQO1) among Iranian ethnic groups
  • Frouzandeh Mahjoubi, NIGEB, Iran
  • Umbilical cord blood biomarkers: early intervention on Fetal Alcohol syndrome
  • Danilo Moretti-Ferreira, São Paulo State University - UNESP, Brazil
  • Genetic analysis of long QT syndrome in New Zealand
  • Ms Carey-Anne Nel, Cardiac Inherited Disease Group, Auckland City Hospital and Department of Obstetrics and Gynaecology, University of Auckland, New Zealand
  • "My baby is safe, I married out." Informed choice in the Jewish genetic screening program
  • Debbie C Redelman, Pacific Laboratory Medicine Services (PaLMS), Australia
  • The “new” x-linked hypotonia – mental retardation syndromes
  • Richard C Rogers, Greenwood Genetic Center, United States
  • Gender and genetic risk
  • Bree Ryan, University of Queensland, Australia
  • Preimplantation genetic diagnosis (PGD) for HLA Matching – The Sydney IVF experience
  • Maria V Traversa, Sydney IVF, Australia
  • Evaluation of High Resolution Melt Analysis for mutation scanning
  • Dr Helen E White, National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, Wiltshire, SP1 3AZ, UK, United Kingdom
  • Reference reagents for genetic testing: development of plasmid based mutation detection reagents by the UK National Genetics Reference Laboratory (Wessex)
  • Dr Helen E White, National Genetics Reference Laboratory (Wessex), Salisbury District Hospital, Salisbury, Wiltshire, SP1 3AZ, UK, United Kingdom
  • Gene assembling, a new approach for molecular diagnosis of hereditary breast cancer
  • Vahid R Yassaee, Shaheed Beheshti University of Medical Sciences, Iran
  • Identification of small regions of copy number changes in fresh and formalin fixed primary ovarian tumors using the Affymetrix® 500K human mapping SNP array
  • Ian G Campbell, Peter MacCallum Cancer Centre, Australia
  • Cytogenetic Screening In NICU and PICU Babies-A Prospective Indian Study
  • Usha P Dave, Centre for Research in Mental Retardation (CREMERE), India
  • “Good evening, I’m calling on behalf of a government agency seeking your opinion on gene therapies … ”
  • Ms Sharon Ding, Biotechnology Australia, Australia
  • Dr Goncalo R Abecasis, University of Michigan, United States
  • Enzyme replacement therapy (ERT) in young children with Mucopolysaccharidosis type I (MPS I) – preliminary results on three patients who started ERT before 24 months of age
  • Roberto Guigliani, Brazil
  • Rare Copy Number Changes Identified In Congenital Heart Disease Using ROMA
  • Vaidehi Jobanputra, Columbia University Medical Center, New York, NY, United States
  • Effect of Sex and Genotype on Gene Expression in Lymphoblastoid Cell Lines from Monozygotic Twins
  • Dr Allan F McRae, Genetic Epidemiology Group, Queensland Institute of Medical Researc; Institute of Evolutionary Biology, University of Edinburgh, Australia
  • The Pompe Registry in Latin America
  • MD, MSc Antonio Abílio P Santa Rosa, Ministério da Saúde, Hospital Geral de Bonsucesso, Latin American Lysosomal Storage Diseases Board of Advisors, Brazil
  • A functional SNP of PTPN22 is associated with childhood-Onset Systemic Lupus Erythematosus, but not with Juvenile Rheumatoid Arthritis in Mexican Population
  • Rafael Velázquez-Cruz, Instituto Nacional de Medicina Genómica, SS; Programa de Doctorado en Ciencias Biomedicas, UNAM, Mexico city, Mexico., Mexico
  • Lorena Orozco, Instituto Nacional de Medicina Genómica, SS, Mexico city, Mexico., Mexico
  • A Preliminary Forensic DNA Program in PR China
  • Wei Wang, China
  • A Microarray-based DNA pooling study based on 100K GeneChip
  • Hsin-Chou Yang, Institute of Biomedical Sciences, Academia Sinica, Taiwan
  • A probabilistic approach to predicting compensatory substitutions for pathogenic mutations
  • Mr Brett C Easton, Centre for Bioinformation Science, John Curtin School of Medical Research and Mathematical Sciences Institute, Australian Natio, Australia
  • A Linear Mixing Model for Probe Responses from SNP Microarrays: Applications to Copy Number Mapping and Clinical Cytogenetics
  • Dr Garry N Hannan, CSIRO Preventative Health Flagship, Sydney, Australia; CSIRO Molecular and Health Technologies, Sydney, Australia;, Australia
  • Alignment of biological sequence pairs using two PHMMs
  • Raymond Sammut, Centre for Bioinformation Science, Australia
  • DNA polymerase gamma mutant proteins have different enzymatic properties but are associated with the same mitochondrial diseases
  • Dr Sherine S Chan, National Institute of Environmental Health Sciences, NIH, United States
  • Lorenzo’s oil treatment: effects on oxidative stress parameters in X-linked adrenoleukodystrophy
  • Roberto Giugliani, Medical Genetics Service, Hospital de Clínicas de Porto Alegre, Brazil
  • Screening for Pompe disease: Further evidences that acarbose is a selective inhibitor of acid and neutral alfa-glucosidase on dried-blood filter paper samples
  • Dr Roberto Giugliani, Medica Genetics Service. HCPA, UFRGS, Brazil, Brazil
  • Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion
  • Julio Montoya, Universidad de Zaragoza, Spain
  • Ms María D Herrero, Universidad de Zaragoza, Spain
  • Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency: the molecular aspect and clinical phenotype
  • Bing-Zhi Yang, Baylor University Medical Center, United States
  • Genome-wide linkage scan for QTL influencing infant growth rate: The Fels Longitudinal Study
  • Dr Ellen W Demerath, Wright State University Boonshoft School of Medicine, United States
  • Genetic Association of the PTPN22 R620W Polymorphism in Familial and Sporadic SLE in European-Americans
  • Kenneth M Kaufman, Oklahoma Medical Research Foundation; US Veterans Affairs Medical Center, OK, United States
  • Clinical and molecular-cytogenetic characterization of three cases of partial 1q duplication
  • Leslie D Kulikowski, Genetics Division, Departament of Morphology, Universidade Federal de São Paulo,SP, Brazil
  • Dr Maria I Melaragno, Genetics Division, Departament of Morphology, Universidade Federal de São Paulo,SP, Brazil
  • Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase
  • Prof Jerzy Nowak, Institute of Human Genetics Pol.Ac.Sci., Poland
  • Chromosome 5q31-33, the cytokine cluster region scanning for the identification of genes associated with asthma
  • Bermseok Oh, National Institute of Health, Korea
  • A Genome-wide Screen Identifies a Quantitative Trait Locus for Human HDL-cholesterol
  • Mr Sampo Sammalisto, Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
  • Influence of the ADH gene family and ALDH2 gene upon in vivo alcohol metabolism in Caucasians
  • Andrew J Birley, Queensland Institute of Medical Research, Brisbane, Australia
  • Association between a 19bp deletion polymorphism at the dopamine ß-hydroxylase locus and migraine with aura
  • Dr Francesca Fernandez, Genomics Research Centre, School of Health Science, Griffith University, Gold Coast, Queensland, Australia
  • DRD4 genotype and activity level predict Alzheimers in the oldest-old
  • Deborah L Grady, Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697, United States
  • Genetic variation of the T-type calcium channel gene CACNA1H in patients with idiopathic epilepsy
  • Ms Sarah E Heron, Department of Genetic Medicine, Women’s and Children’s Hospital, North Adelaide, South Australia., Australia
  • Quantification of Relative Gene Dosage by Single Base Extension and High-Performance Liquid Chromatography: Application to SMN1/SMN2 Gene
  • Mr Chia-Cheng Hung, Institute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan
  • Common variation the glucocorticoid receptor locus modifies the association between length at birth and glucose tolerance in adult life
  • Eero Kajantie, National Public Health Institute, Finland
  • Gene expression analyses of liver, and omental and subcutaneous adipose tissue, from morbidly obese subjects
  • Dr Donia Macartney, Institute of Environmental Science and Research, New Zealand
  • Gene mapping studies in endometriosis families
  • Grant W Montgomery, Queensland Institute of Medical Research, Australia
  • Sensitive detection of polyalanine tract of PHOX2B by PCR using deaminated DNA: no association of sudden infant death syndrome with congenital central hypoventilation syndrome
  • Motoki Osawa, Department of Forensic Medicine, Tokai University School of Medicine, Japan
  • Genetic susceptibility to fetal alcohol syndrome (FAS): Candidate gene association studies in South African Coloured populations
  • Michele Ramsay, NHLS and University of the Witwatersrand, South Africa
  • Electrocardiography in Down syndrome patients: late maturation, early aging
  • Prof Dr Algimantas Sinkus, Kaunas University of Medicine, Lithuania
  • Linkage and association between polycystic ovary syndrome and chromosome 19p13.2
  • Prof R S Spielman, University of Pennsylvania, United States
  • Repetitive and sequence TSPY gene polymorphism in infertile men and immunofluorescent Tspy protein detection in paraffin embedded seminomal tissues
  • Dr Radek Vrtel, Department of Clinical genetics and foetal Medicine, University Hospital Olomouc, Czech Republic
  • Genome-wide association study combining incomplete high resolution SNP data with sparse markers from a linkage scan
  • Wei-Min Chen, University of Michigan, United States
  • Haplotype analysis of the methylenetetrahydrofolate reductase (MTHFR) gene in the Sri Lankan population
  • Dr Vajira HW Dissanayake, Human Genetics Unit, Faculty of Medicine, University of Colombo, Sri Lanka
  • Sequencing and recombination analysis identify HLA-C as the psoriasis gene at PSORS1, the major susceptibility locus on chromosome 6
  • Rajan P Nair, University of Michigan, United States
  • Homozygosity mapping using Whole Genome SNP chips to identify a region of linkage disequilibrium
  • Margit Burmeister, Molecular & Behavioral Neuroscience Inst., University of Michigan, United States
  • Prevalence, impact and genetics of slight/mild sensorineural hearing loss in school age children
  • A/Prof Hans-Henrik M Dahl, Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne & Department of Paediatrics, University of Melbourne, Australia
  • Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian kindreds with nephrogenic diabetes insipidus
  • Luiz De Marco, Universidade Federal de Minas Gerais, Brazil
  • Loss of aprataxin function associated with early-onset ataxia impairs DNA single strand break repair
  • Makito Hirano, Nara Medical University, Department of Neurology, Japan
  • A proposed new strategy for identifying genetic disease genes
  • Prof Landian Hu, Health Science Institute, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiaotong Univer, China
  • Dural ectasias associated with novel TGFBR2 mutation in Dutch type II Marfan syndrome family
  • A M Lachmeijer, Dept of Clinical Genetics and Human Genetics, VU University medical centre, Amsterdam, the Netherlands, The Netherlands
  • Novel slow-skeletal/beta cardiac myosin mutations in Laing early onset distal myopathy and myosin storage myopathy
  • Nigel Laing, University of Western Australia, Australia
  • Characterization of the KRAB/ZNF gene cluster on Xp11 involved in mental retardation
  • Dorien Lugtenberg, Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
  • Detailed Haplotype Analysis of the HD Gene
  • Alexandre Montpetit, McGill University and Genome Quebec Innovation Centre, Montreal, Canada
  • Complex genetic approaches to monogenic disease: Genomic and transcriptomic dissection of normal expression of CTNS, the gene involved in nephropathic cystinosis
  • Dr Eric K Moses, Southwest Foundation for Biomedical Research, San Antonio, Texas, United States
  • Interaction between a KCNQ1 mutation and Cell Stretch in Familial Atrial Fibrillation
  • Robyn T Otway, Victor Chang Cardiac Research Institute, Australia
  • A Novel Pathogenic Mutation and Possible Synergistic Heterozygosity Contributing to Respiratory Chain Complex I Deficiency
  • Dr Renato Salemi, Murdoch Children's Research Institute, Royal Children’s Hospital, Melbourne, Australia
  • Locus and allelic heterogeneity in Lafora's progressive myoclonus epilepsy: Novel mutations in EPM2A and NHLRC1 genes and genotype-phenotype correlations
  • Shweta Singh, Indian Institute of Technology, Kanpur, India
  • From DNA to phenotype: A study about the involvement of the Fragile X Syndrome molecular mechanisms on the clinical characteristics of female carriers
  • Isabel Tejada, Laboratorio de Genética Molecular. Hospital de Cruces. Baracaldo, Bizkaia., Spain
  • Atypical Beckwith-Wiedemann phenotype, bilateral phaeochromocytomas, cerebral and renal artery stenoses, associated with segmental uniparental disomy of 11p and 11q
  • Dr Meredith Wilson, Children's Hospital Westmead, Australia
  • Fabry Management Team – the NSW experience
  • Ms Kerry Devine, Westmead Hospital NSW Australia 2145, Australia
  • Inhibition of Aberrant Splicing of IVSI-110 β-globin pre-mRNA by Antisense Oligonucleotide
  • Dr Sima Mansoori Derakhshan, Cell and Gene Therapy Group, The Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, Australia., Australia
  • Upregulation of ABCD2 through VPA: a new therapeutic approach for X-adrenoleukodystrophy?
  • Aurora Pujol, Centre de Genètica Mèdica i Molecular IDIBELL, Spain
  • Humanised Mouse Models for Common β-Thalassemia Mutations
  • Dr Jim Vadolas, Cell and Gene Therapy Group, The Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne, Australia., Australia
  • Making sense in spite of nonsense: a splice intervention therapy for Duchenne Muscular Dystrophy
  • A/Prof Steve D Wilton, Australian Neuromuscular Research Institute, QE II Medical Centre, Nedlands, WA, Australia
  • Identification of Novel Genes in Eye Development in Balanced Translocation Patients
  • Ms Marija Mihelec, Eye Genetics Group, Embryology Unit, CMRI; The Children's Hospital at Westmead; Save Sight Institute, University of Sydney, Australia
  • A Human Specific Change in FZD10 Gene involved in Limb Development
  • Rowena F Stern, Cambridge Institute for Medical Research, United Kingdom
  • Identification of candidate disease genes using genomics based screening approaches
  • Dr Carol Wicking, Institute for Molecular Bioscience, The University of Queensland, Australia
  • Disruption of conserved non-coding elements in a t(10;13)(q26;q31)de novo
  • Ms Elizabeth Engenheiro, Wilhelm Johannsen Centre for Functional Genome Research, Department of Medical Genetics, IMBG, University of Copenhagen, Denmark
  • Comparative analysis of chimpanzee and human Y chromosomes unveils complex evolutionary pathway
  • Yoko Kuroki, RIKEN Genomic Sciences Center, Japan
  • Global Ethical, Legal, Social and Regulatory Strategies for Integrating Pharmacogenetic Research into Large Scale Clinical Trials
  • Beth Balkite, Genetics Research, GlaxoSmithKline, United States
  • The Jameslink-OSUCAP in the Community: Impact of a Cancer Risk Assessment Program
  • Kimberly M Kelly, The Ohio State University, United States
  • The dilemma of Late Stage Care in Huntington's Disease
  • Dr Sheila A Simpson, Clinical Genetics, NHS Grampian, United Kingdom
  • Prenatal screening: informed decision-making, routinization and resistance
  • Brenda J Wilson, University of Ottawa, Canada
  • SOX9cre1: a distal SOX9 regulator that interacts with Hh signaling factors
  • Gabriel A Bien-Willner, Baylor College of Medicine, Houston, Texas, United States
  • Possible sequence elements involved in the epigenetic formation of ectopic centromere chromatin
  • Anderly C Chueh, Murdoch Childrens Research Institute, Australia
  • Effect of Size on Virtual Population Growth
  • M Linton Herbert, Sun Coast Hospital, United States
  • Characterisation of chromatin and centromere behaviour in Roberts syndrome
  • Jeffrey M Craig, Murdoch Childrens Research Institute, Australia
  • Migraine susceptibility genotypes and B vitamins as a prophylactic treatment
  • Natalie J Colson, Genomics Research Centre, Australia
  • Rosiglitazone in Alzheimer's Disease: Efficacy Pharmacogenetics and Support for a Pathogenetic Hypothesis of Disease
  • Ann M Saunders, Research and Development, GlaxoSmithKline, United States
  • Vanishing white matter (VWM) disease as a cause of progressive myoclonus epilepsy
  • Eva Andermann, Montreal Neurological Hospital and Institute, McGill University, Canada
  • Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease
  • Craig L Bennett, University of Washington, United States
  • Depletion and 4,977 bp Deletion of Mitochondrial DNA in Leukocytes of Patients with Mitochondrial Disorders and Neurodegenerative Diseases
  • Wen-Ling Cheng, Department of Neurology and Vascular & Genomic Center, Changhua Christian Hospital, Changhua, Taiwan 500, Taiwan
  • SCN1A Mutations and Epilepsy
  • Leanne M Dibbens, Department of Genetic Medicine, Women's and Children's Hospital, Adelaide, South Australia, Australia
  • Clinical and molecular genetic analysis of idiopathic generalized epilepsy in Kuwaiti Arab children
  • Prof Mohammad Z Haider, Kuwait University, Faculty of Medicine, Pediatrics Department, Kuwait
  • A New Autosomal Recessive Model for Demyelinating Neuropathy?
  • Chelsee A Hewitt, The Walter and Eliza Hall Institute, Australia
  • A nonsense mutation of GABRG2 found in a sever epilepsy phenotype leading to trafficking abnormality of GABAA receptors and apoptosis
  • Mr Atsushi Ishii, Department of Pediatrics, School of Medicine, Fukuoka University, Japan
  • Schizencephaly as a result of thrombocytopaenic fetal brain haemorrhage
  • George McGillivray, Murdoch Children's Research Institute, Australia
  • Familial aggregation and age of onset in Parkinson’s disease
  • Dr George D Mellick, Princess Alexandra Hospital, Australia
  • Characterisation of abnormalities of alpha-dystroglycan in a cohort of Australian patients
  • Dr Janine M Smith, Institute for Neuromuscular Research, Department of Clinical Genetics, Children’s Hospital at Westmead, Discipline of Paediatri, Australia
  • ApoE4 Allele Frequency and Alteration of Vitamin E in Patients with Alzheimer's Disease
  • Cheng-Yu Wang, Information System Department; Vascular and Genomic Center, Changhua Christian Hospital, Changhua, Taiwan, Taiwan
  • Can MSRV be engaged in a development of multiple sclerosis?
  • Mariola Zawada, Institute of Human Genetics Polish Academy of Sciences, Poznan, Poland, Poland
  • Parental smoking impairs vaccine responses in children with atopic genotypes
  • Dr Gareth S Baynam, Genetic Services of Western Austrlia and Telethon Institute for Child Health Research, Australia
  • Genetic analysis of molecules related to dsRNA recognition in subacute sclerosing panencephalitis
  • Dr Toshiro Hara, Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Japan
  • Verbal and non-verbal abilities in Williams-Beuren syndrome
  • Danilo Moretti-Ferreira, São Paulo State University - UNESP, Brazil
  • Published on Tuesday, 1 August 2006 by the Professional Conference Organiser